Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

All Articles

Family Meeting
Paul Kidwell shares his devastating experience at a family gathering for his 31-year-old nephew, who was diagnosed with stage IV colorectal cancer at age 25 and had only weeks to live. Read More ›

Life After a Cancer Diagnosis
Julie Silver ran into many “bumps in the road” after she was diagnosed with stage IV ovarian cancer. Despite many difficulties along the way, today her life is filled with gratitude and appreciation. Read More ›

Fishing for Our Souls
Cancer survivor Tricia Tennesen recounts her spirit-lifting experience with a group of survivors on a nature retreat that involved fly-fishing, which offered her a “path to spirituality without doctrine or dogma.” Read More ›

Ibrutinib is an orally administered Bruton tyrosine kinase inhibitor used in the treatment of patients with CLL. Because ibrutinib has been prescribed in the United States for several years, researchers sought to learn how the rates of side effects in the “real world” compared with those reported in clinical trials. Read More ›

When treating patients with CLL, understanding specific details about the disease helps doctors as they choose among available treatments. CLL experts believe that conducting specific blood tests before prescribing each patient’s treatment is critical. Do all doctors who treat patients with CLL also appreciate this need for testing? Read More ›

In a large clinical trial, ibrutinib was shown to be effective in delaying disease progression in patients with early-stage, high-risk CLL who did not yet have symptoms. Researchers are now conducting clinical trials to determine the safety and efficacy of next-generation drugs and combinations in patients with early-stage, high-risk disease. Read More ›

In the era of targeted treatments for CLL, should patients with early-stage disease be placed on therapy before they experience symptoms? Doctors continue to debate this question while waiting for clinical trial data to evolve. Read More ›

Chronic lymphocytic leukemia (CLL) is a type of blood cancer. Some patients with CLL may not need treatment right away, whereas others require more urgent attention. How do cancer specialists decide when to start patients on therapy? Read More ›

Know Your Melanoma
Melanoma is a type of skin cancer that begins in the melanocytes, skin cells that give the skin its color. Melanoma is a serious cancer, but when caught early, it is highly treatable. Read More ›

The Importance of Receiving Patient-Centered Care
What is Patient-Centered Care? It means that you are much more than a breast cancer diagnosis. Sharing the essence of who you are will help your healthcare team to provide the patient-centered care you deserve. Read More ›

Page 84 of 164